Brentuximab vedotin 認識化療藥品Brentuximab
2026/7/21
Adcetris® is an antibody-drug conjugate combining a cytotoxic agent with a selective monoclonal antibody, which targets a protein called CD30 on the surface of some lymphoma cells, and delivers a cytotoxic agent to destroy the cancer cells.